| 产品描述: | Asenapine (Org 5222), an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine can be used in the research of schizophrenia and bipolar disorder |
| 靶点: |
5-HT1A Receptor:8.6 (pKi);5-HT1B Receptor:8.4 (pKi);5-HT2A Receptor:10.2 (pKi);5-HT2B Receptor:9.8 (pKi);5-HT2C Receptor:10.5 (pKi);5-HT5 Receptor:8.8 (pKi);5-HT6 Receptor:9.6 (pKi);5-HT7 Receptor:9.9 (pKi);Alpha-2A adrenergic receptor:8.9 (pKi);α1-adrenergic receptor:8.9 (pKi);Alpha-2B adrenergic receptor:9.5 (pKi);Alpha-2C adrenergic receptor:8.9 (pKi);D1 Receptor:8.9 (pKi);D2 Receptor:8.9 (pKi);D3 Receptor:9.4 (pKi);D4 Receptor:9.0 (pKi);H1 Receptor:9.0 (pKi);H2 Receptor:8.2 (pKi) |
| 体内研究: |
Asenapine (0.05-0.2 mg/kg; s.c.) induces a dose-dependent suppression of conditioned avoidance response (CAR) and does not induce catalepsy |
| 参考文献: |
1. M Shahid, et al. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. 2. Olivia Frånberg, et al. Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia. Psychopharmacology (Berl). 2008 Feb;196(3):417-29. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.499 ml |
17.497 ml |
34.993 ml |
| 5 mM |
0.7 ml |
3.499 ml |
6.999 ml |
| 10 mM |
0.35 ml |
1.75 ml |
3.499 ml |
| 50 mM |
0.07 ml |
0.35 ml |
0.7 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |